Key result
Omitting pre-extraction empiric IV antibiotics in selected CIED infections is linked to ~2-week shorter hospital stays.
Why the study?
The study aimed to evaluate risk factors, management strategies, and clinical outcomes in patients with CIED infections to help optimize treatment pathways and reduce reinfection rates.
Does omitting inpatient empirical intravenous antibiotics prior to device extraction reduce hospital stay without compromising infection resolution and six-month reinfection rates in patients with confirmed cardiac implantable electronic device infections?
Observational (n=100)
Open-label
No
Does omitting inpatient empirical intravenous antibiotics prior to device extraction reduce hospital stay without compromising infection resolution and six-month reinfection rates in patients with confirmed cardiac implantable electronic device infections?
Answers are grounded in this paper and cite their sources.
In selected patients with uncomplicated CIED pocket infections, omitting inpatient empirical IV antibiotics prior to device extraction via a structured outpatient workflow was associated with a shorter total hospital stay without increasing reinfection or mortality, though findings are subject to confounding by baseline infection severity.
Objectives: To evaluate risk factors, management strategies, and clinical outcomes in patients with cardiac implantable electronic device (CIED) infections, with a focus on optimizing treatment pathways and reducing reinfection rates. Methods: This prospective observational registry included 100 patients with confirmed CIED infections managed at the National Heart Institute, Egypt, between December 2021 and April 2023. Patients were categorized based on whether inpatient empirical intravenous antibiotics were administered prior to device extraction. Data collected included demographics, clinical characteristics, microbiological findings, management approaches, and outcomes. The primary outcomes were infection resolution and reinfection within six months, while secondary outcomes included hospital stay, antibiotic duration, rehospitalization, and mortality. Results: Early infections (<1 year) accounted for 45% of cases, while delayed infections (>1 year) comprised 55%. Culture positivity was observed in 40% of patients, predominantly due to coagulase-negative staphylococci (32.5%). The median time from diagnosis to device extraction was 2 weeks (IQR 2–3). Patients managed without inpatient empirical intravenous antibiotics prior to extraction had significantly shorter hospital stays (median 4 [3–4] weeks vs. 6 [4–6] weeks, P = 0.005), while antibiotic duration before and after device removal did not differ significantly (P = 0.059 for both). Re-implantation was performed in 82% of patients. No in-hospital mortality occurred, and reinfection was observed in 2% during six-month follow-up. Conclusions: In this prospective registry, a selected management pathway involving omission of inpatient empirical intravenous antibiotics prior to extraction in carefully chosen patients was associated with shorter hospital stay without compromising infection control. However, given the observational design and baseline differences between groups, these findings should be interpreted as associative rather than causal and warrant further investigation in controlled studies.
No takes yet. Share an insight, caveat, or question.
Sadek et al. (2026) conducted an observational in Cardiac implantable electronic device (CIED) infections (n=100). Omission of inpatient empirical intravenous antibiotics prior to device extraction vs. Inpatient empirical intravenous antibiotics prior to device extraction was evaluated on Recurrent infection within 6 months (p=0.638). Omitting pre-extraction inpatient empirical IV antibiotics in selected CIED infection patients was associated with shorter hospital stays and 100% infection resolution.
Synapse has enriched 10 related papers. Consider them for comparative context: